Journal: bioRxiv
Article Title: ATR facilitates the degradation of Api5 through the ubiquitin-proteasome pathway via FBXW2 to regulate apoptosis upon DNA damage
doi: 10.1101/2021.08.08.455545
Figure Lengend Snippet: ( A) MCF7 cells were treated with 50 J/m 2 UV and ATRi (20μM VE821 for 12 hrs) were lysed 12 hrs post UV and levels of Api5, pRPA and RPA were analysed using western blotting. (B) The fold change of Api5 was quantified after normalisation with GAPDH. (C) Immunofluorescence assay was performed on MCF7 cells treated with 50 J/m 2 UV and ATRi (20μM VE821 for 12 hrs) using Api5 specific antibody and (D) Api5 localisation was manually analysed. mCherry-tagged Api5 over-expressing MCF7 cells treated with 50 J/m 2 UV were lysed 12 hrs post treatment and immunoprecipitation was performed using (E) GFP and (F) ATR-specific antibody. Western blotting analysis was performed to analyse the presence of ATR and GFP respectively.
Article Snippet: Camptothecin (C9911), Etoposide (E1383), Protease inhibitor cocktail (P2714), dimethyl sulfoxide (DMSO), propidium iodide (P4170) Chloroquine (C6628), MG132 (M7449), Cyclohexamide (C1988), polybrene (Hexadimethrine bromide; H9268), thiazolyl blue tetrazolium (MTT; M5655) and dimethyl sulfoxide (DMSO; D8418) were purchased from Sigma-Aldrich; romidepsin (FK228, Depsipeptide) was from Seleck Chemicals, USA and the selective ATR kinase ATR inhibitor (VE 821) was purchased from Axon Medchem, USA.
Techniques: Western Blot, Immunofluorescence, Expressing, Immunoprecipitation